These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 32440702)

  • 1. Evidence of distinct α-synuclein strains underlying disease heterogeneity.
    Holec SAM; Woerman AL
    Acta Neuropathol; 2021 Jul; 142(1):73-86. PubMed ID: 32440702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism.
    Prusiner SB; Woerman AL; Mordes DA; Watts JC; Rampersaud R; Berry DB; Patel S; Oehler A; Lowe JK; Kravitz SN; Geschwind DH; Glidden DV; Halliday GM; Middleton LT; Gentleman SM; Grinberg LT; Giles K
    Proc Natl Acad Sci U S A; 2015 Sep; 112(38):E5308-17. PubMed ID: 26324905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple system atrophy prions retain strain specificity after serial propagation in two different Tg(SNCA*A53T) mouse lines.
    Woerman AL; Oehler A; Kazmi SA; Lee J; Halliday GM; Middleton LT; Gentleman SM; Mordes DA; Spina S; Grinberg LT; Olson SH; Prusiner SB
    Acta Neuropathol; 2019 Mar; 137(3):437-454. PubMed ID: 30690664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique seeding profiles and prion-like propagation of synucleinopathies are highly dependent on the host in human α-synuclein transgenic mice.
    Lloyd GM; Sorrentino ZA; Quintin S; Gorion KM; Bell BM; Paterno G; Long B; Prokop S; Giasson BI
    Acta Neuropathol; 2022 Jun; 143(6):663-685. PubMed ID: 35488930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple system atrophy-associated oligodendroglial protein p25α stimulates formation of novel α-synuclein strain with enhanced neurodegenerative potential.
    Ferreira N; Gram H; Sorrentino ZA; Gregersen E; Schmidt SI; Reimer L; Betzer C; Perez-Gozalbo C; Beltoja M; Nagaraj M; Wang J; Nowak JS; Dong M; Willén K; Cholak E; Bjerregaard-Andersen K; Mendez N; Rabadia P; Shahnawaz M; Soto C; Otzen DE; Akbey Ü; Meyer M; Giasson BI; Romero-Ramos M; Jensen PH
    Acta Neuropathol; 2021 Jul; 142(1):87-115. PubMed ID: 33978813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial Parkinson's point mutation abolishes multiple system atrophy prion replication.
    Woerman AL; Kazmi SA; Patel S; Aoyagi A; Oehler A; Widjaja K; Mordes DA; Olson SH; Prusiner SB
    Proc Natl Acad Sci U S A; 2018 Jan; 115(2):409-414. PubMed ID: 29279394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmission of prion strains in a transgenic mouse model overexpressing human A53T mutated α-synuclein.
    Mougenot AL; Bencsik A; Nicot S; Vulin J; Morignat E; Verchère J; Bétemps D; Lakhdar L; Legastelois S; Baron TG
    J Neuropathol Exp Neurol; 2011 May; 70(5):377-85. PubMed ID: 21487306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of α-synuclein prions preceding neuropathological inclusions in multiple system atrophy.
    Woerman AL; Patel S; Kazmi SA; Oehler A; Lee J; Mordes DA; Olson SH; Prusiner SB
    PLoS Pathog; 2020 Feb; 16(2):e1008222. PubMed ID: 32017806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prominent microglial inclusions in transgenic mouse models of α-synucleinopathy that are distinct from neuronal lesions.
    Tanriöver G; Bacioglu M; Schweighauser M; Mahler J; Wegenast-Braun BM; Skodras A; Obermüller U; Barth M; Kronenberg-Versteeg D; Nilsson KPR; Shimshek DR; Kahle PJ; Eisele YS; Jucker M
    Acta Neuropathol Commun; 2020 Aug; 8(1):133. PubMed ID: 32787922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ɑ-Synuclein strains and the variable pathologies of synucleinopathies.
    Peelaerts W; Baekelandt V
    J Neurochem; 2016 Oct; 139 Suppl 1():256-274. PubMed ID: 26924014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α-Synuclein strain propagation is independent of cellular prion protein expression in a transgenic synucleinopathy mouse model.
    So RWL; Amano G; Stuart E; Ebrahim Amini A; Aguzzi A; Collingridge GL; Watts JC
    PLoS Pathog; 2024 Sep; 20(9):e1012517. PubMed ID: 39264912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies.
    Peng C; Gathagan RJ; Lee VM
    Neurobiol Dis; 2018 Jan; 109(Pt B):209-218. PubMed ID: 28751258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-Synuclein strains target distinct brain regions and cell types.
    Lau A; So RWL; Lau HHC; Sang JC; Ruiz-Riquelme A; Fleck SC; Stuart E; Menon S; Visanji NP; Meisl G; Faidi R; Marano MM; Schmitt-Ulms C; Wang Z; Fraser PE; Tandon A; Hyman BT; Wille H; Ingelsson M; Klenerman D; Watts JC
    Nat Neurosci; 2020 Jan; 23(1):21-31. PubMed ID: 31792467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodegenerative phenotypes in an A53T α-synuclein transgenic mouse model are independent of LRRK2.
    Daher JP; Pletnikova O; Biskup S; Musso A; Gellhaar S; Galter D; Troncoso JC; Lee MK; Dawson TM; Dawson VL; Moore DJ
    Hum Mol Genet; 2012 Jun; 21(11):2420-31. PubMed ID: 22357653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential seeding and propagating efficiency of α-synuclein strains generated in different conditions.
    Liu D; Guo JJ; Su JH; Svanbergsson A; Yuan L; Haikal C; Li W; Gouras G; Li JY
    Transl Neurodegener; 2021 Jun; 10(1):20. PubMed ID: 34148543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From Posttranslational Modifications to Disease Phenotype: A Substrate Selection Hypothesis in Neurodegenerative Diseases.
    Baskakov IV
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel panel of α-synuclein antibodies reveal distinctive staining profiles in synucleinopathies.
    Dhillon JS; Riffe C; Moore BD; Ran Y; Chakrabarty P; Golde TE; Giasson BI
    PLoS One; 2017; 12(9):e0184731. PubMed ID: 28910367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated accumulation of retinal α-synuclein (pSer129) and tau, neuroinflammation, and autophagic dysregulation in a seeded mouse model of Parkinson's disease.
    Mammadova N; Summers CM; Kokemuller RD; He Q; Ding S; Baron T; Yu C; Valentine RJ; Sakaguchi DS; Kanthasamy AG; Greenlee JJ; Heather West Greenlee M
    Neurobiol Dis; 2019 Jan; 121():1-16. PubMed ID: 30218757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracranial administration of alpha-synuclein fibrils in A30P-synuclein transgenic mice causes robust synucleinopathy and microglial induction.
    Gentzel RC; Toolan D; Jinn S; Schachter JB; Ma L; Kahle PJ; Smith SM; Marcus JN
    Neurobiol Aging; 2021 Oct; 106():12-25. PubMed ID: 34225000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prion-like propagation of α-synuclein in neurodegenerative diseases.
    Tarutani A; Hasegawa M
    Prog Mol Biol Transl Sci; 2019; 168():323-348. PubMed ID: 31699325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.